Page last updated: 2024-08-17

ethyl methanesulfonate and Kahler Disease

ethyl methanesulfonate has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harada, N; Hata, H; Matsuno, F; Matsuzaki, H; Mitsuya, H; Nagasaki, A1

Other Studies

1 other study(ies) available for ethyl methanesulfonate and Kahler Disease

ArticleYear
Down-regulation of CD98 in melphalan-resistant myeloma cells with reduced drug uptake.
    Acta haematologica, 2000, Volume: 103, Issue:3

    Topics: Antigens, CD; Antigens, Neoplasm; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Carrier Proteins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ethyl Methanesulfonate; Fusion Regulatory Protein-1; Gene Expression Regulation, Neoplastic; Glutamate-Cysteine Ligase; Humans; Melphalan; Multidrug Resistance-Associated Proteins; Multiple Myeloma; Mutagenesis; Neoplasm Proteins; Phenylalanine; Structure-Activity Relationship; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles

2000